Aim Bulletin
Ondine reports significant financial growth
By Josh White
Date: Wednesday 24 Apr 2024
(Sharecast News) - Ondine Biomedical reported significant growth in a trading update on Wednesday, with revenues doubling to $1.2m in 2023, driven by expanded hospital deployments of 'Steriwave'.
The AIM-traded company said it now served 24 hospitals, including strategic gains in the UK and Spain, and its first deployment in Australia.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
